These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39279560)

  • 1. Pyruvate kinase modulators as a therapy target: an updated patent review 2018-2023.
    Adem S; Rasul A; Riaz S; Sadiqa A; Ahmad M; Shahid Nazir M; Hassan M
    Expert Opin Ther Pat; 2024 Oct; 34(10):953-962. PubMed ID: 39279560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate kinase activators as a therapy target: a patent review 2011-2017.
    Adem S; Comakli V; Uzun N
    Expert Opin Ther Pat; 2018 Jan; 28(1):61-68. PubMed ID: 28994333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PKM2 in cancer progression and its structural and biological basis.
    Wu B; Liang Z; Lan H; Teng X; Wang C
    J Physiol Biochem; 2024 May; 80(2):261-275. PubMed ID: 38329688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1 regulates PKM2 function through Akt phosphorylation.
    Salani B; Ravera S; Amaro A; Salis A; Passalacqua M; Millo E; Damonte G; Marini C; Pfeffer U; Sambuceti G; Cordera R; Maggi D
    Cell Cycle; 2015; 14(10):1559-67. PubMed ID: 25790097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
    Chhipa AS; Patel S
    Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
    Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2.
    Wang RH; Chen PR; Chen YT; Chen YC; Chu YH; Chien CC; Chien PC; Lo SY; Wang ZL; Tsou MC; Chen SY; Chiu GS; Chen WL; Wu YH; Wang LH; Wang WC; Lin SY; Kung HJ; Wang LH; Cheng HC; Lin KT
    Nat Commun; 2024 Aug; 15(1):7463. PubMed ID: 39198443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
    Tamada M; Suematsu M; Saya H
    Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.
    Nandi S; Dey M
    J Biol Chem; 2020 Apr; 295(16):5390-5403. PubMed ID: 32144209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen treatment in combination with pyruvate kinase M2 inhibition precipitate significant cumulative antitumor effects in colorectal cancer.
    Zamer BA; Cui ZG; Eladl MA; Hamad M; Muhammad JS
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23799. PubMed ID: 39132768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications.
    Chen P; Lou L; Sharma B; Li M; Xie C; Yang F; Wu Y; Xiao Q; Gao L
    Curr Med Chem; 2024; 31(20):2955-2973. PubMed ID: 37455458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
    Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
    Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the interaction between PKM2 and the built-in thermodynamic properties of the glycolytic pathway in cancer cells.
    Jin C; Hu W; Wang Y; Wu H; Zeng S; Ying M; Hu X
    J Biol Chem; 2024 Sep; 300(9):107648. PubMed ID: 39121998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.